Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telotristat Ethyl for Weight Loss in Advanced Pancreatic Cancer
NCT03910387Phase 2Completed
- Sponsor
- Emory University
- Start
- Apr 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of telotristat ethyl in cachexia (2 arms), sponsored by Emory University. Primary endpoint: Weight Stability at 3 months. Started Apr 2019; status: completed.
02
Drugs
telotristat ethyl
03
Conditions
cachexia
Beyond the preview
Go deeper on NCT03910387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03910387.